Table 2.
Measured time point | Treatment group mean (SD) | Control group mean (SD) |
---|---|---|
Brief Pain Inventory-Interference | ||
T1 | 4.60 (2.39) | 4.28 (2.40) |
T2 | 4.32 (2.37) | 4.08 (2.39) |
T3 | 3.40 (2.34) | 3.92 (2.61) |
T4 | 3.49 (2.09) | 3.58 (2.61) |
Profile of Mood States | ||
T1 | 67.42 (14.97) | 62.72 (13.68) |
T2 | 65.04 (15.44) | 63.21 (14.8) |
T3 | 61.42 (15.02) | 63.37 (14.89) |
T4 | 62.88 (16.67) | 60.92 (16.46) |
Patient Global Impression of Change | ||
T1 | N/A | N/A |
T2 | 4.29 (1.14) | 4.24 (.94) |
T3 | 5.11 (.71) | 4.14 (1.15) |
T4 | 5.06 (.98) | 4.40 (1.22) |
Patient Health Questionnaire-9 | ||
T1 | 9.36 (5.99) | 10.48 (6.54) |
T2 | 9.15 (5.71) | 9.54 (5.71) |
T3 | 9.49 (5.25) | 8.05 (5.12) |
T4 | 7.61 (4.73) | 7.85 (5.34) |
Five Facet Mindfulness Questionnaire | ||
T1 | 122.35 (21.72) | 127.91(20.67) |
T2 | 125.43 (22.75) | 130.04 (22.81) |
T3 | 132.19 (20.20) | 130.56 (22.37) |
T4 | 132.94 (23.55) | 132.98 (22.79) |
Pain Catastrophizing Scale | ||
T1 | 21.69 (11.77) | 19.26 (12.16) |
T2 | 20.09 (10.57) | 19.19 (11.54) |
T3 | 15.00 (11.08) | 17.60 (11.81) |
T4 | 16.28 (12.09) | 14.73 (11.11) |
Neuropathic Pain Symptom Inventory | ||
T1 | 0.40 (0.17) | 0.43 (0.16) |
T2 | 0.42 (0.17) | 0.42 (0.16) |
T3 | 0.37 (0.14) | 0.39 (0.18) |
T4 | 0.37 (0.16) | 0.37 (0.17) |
Short-Form-12 Health Survey-physical health T-score | ||
T1 | 32.49 (10.15) | 35.19 (10.38) |
T2 | 33.99 (9.61) | 36.17 (10.27) |
T3 | 37.59 (10.25) | 35.10 (10.56) |
T4 | 36.36 (12.22) | 37.21 (12.20) |
Short-Form-12 Health Survey-mental health T-score | ||
T1 | 43.07 (12.13) | 46.64 (10.95) |
T2 | 45.94 (12.78) | 47.06 (11.10) |
T3 | 48.17 (10.37) | 46.69 (11.16) |
T4 | 48.98 (10.69) | 48.44 (10.96) |
T1: before medical optimization; T2: after randomization; T3: 2 weeks post-MBSR (and equivalent time point for waitlist control group); T4: 3 months post-MBSR (and equivalent time point for waitlist control group).